A Look Into Biogen Inc's Price Over Earnings
Portfolio Pulse from Benzinga Insights
Biogen Inc.'s (NASDAQ:BIIB) share price is currently at $281.65, after a 0.03% increase. Over the past month, the stock fell by 5.68%, but in the past year, it spiked by 37.28%. The company's P/E ratio of 13.11 is lower than the Biotechnology industry average of 50.2, which could indicate that the stock is undervalued or that it might perform worse than its industry peers.
June 27, 2023 | 6:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Biogen's P/E ratio is lower than the industry average, which could suggest that the stock is undervalued or may underperform compared to its peers.
A lower P/E ratio can indicate that a stock is undervalued, which could lead to an increase in price if the market corrects this undervaluation. However, it could also suggest that the company may underperform compared to its peers, which could negatively impact the stock price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100